Epitope-specific regulation. II. A bistable, Igh-restricted regulatory mechanism central to immunologic memory by Herzenberg, LA et al.
EPITOPE-SPECIFIC  REGULATION 
II. A  Bistable, Igh-restricted Regulatory 
Mechanism  Central to Immunologic  Memory* 
BY  LEONORE  A.  HERZENBERG, TAKESHI TOKUHISA,~ DAVID  R.  PARKS, 
AND  LEONARD  A.  HERZENBERG 
From the Department of Genetics, Stanford University School of Medicine, Stanford, California 94305 
Bistable systems, by definition, have two  alternative steady states with mutually 
exclusive functions. When confronted initially with a  stimulus favoring one state or 
the other, these systems move rapidly to the favored state. Stabilization mechanisms 
then maintain the  initially induced state,  so  that  a  substantially stronger signal is 
required to move to the other steady state than would have been required to establish 
that  state  initially. Thus, bistable systems tend to  remain as  initially induced, but 
nonetheless remain capable of shifting to the alternate state if stimulatory conditions 
so dictate. 
The electronic binary ("flip-flop") circuit is frequently cited as the typical example 
of a bistable system; however, systems with similar behavior are well known in biology 
(e.g., enzyme induction in bacteria and hormonal regulation in higher organisms). In 
addition,  as  we  show  here,  the  epitope-specific  regulatory  system  that  selectively 
controls antibody production to individual epitopes on antigenic (carrier)  molecules 
(1-4) 1'2 operates as a  typical bistable mechanism. 
This system, we will show, is composed of Igh-restricted, epitope-specific elements 
that can be induced to either support or suppress the production of antibody molecules 
with distinctive Ig heavy chain constant region (isotype) and combining-site  structures. 
Because these elements are independently inducible, different types of immunizations 
with an epitope such as DNP (dinitrophenyl hapten on a carrier molecule) can induce 
either suppression for all IgG anti-DNP responses, support for all such responses or 
selective suppression for certain isotype or allotype responses, and concomitant support 
for others. 
The  selective  isotype  regulation  demonstrated  here  in  IgG  anti-DNP  responses 
* Supported  in  part  by  grants  HD-02187 and CA-04681 from the  National  Institutes of Health, 
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l We have previously called this regulatory mechanism hapten-specific, using the term hapten in its 
more general sense (synonymous  with epitope) to indicate a relatively small structure that induces antibody 
production when presented on a larger (carrier) molecule. This term, however, is also commonly used to 
distinguish artificially added structures, such as the dinitrophenyl phenyl group (DNP) from the native 
epitopes on a carrier molecule (antigen). Therefore, to avoid ambiguity, we have now substituted the term 
epitope-specific for the previous nomenclature. 
2 Herzenberg, L. A., T. Tokuhisa, D. R. Parks, and L. A. Herzenberg. Epitope-specific  regulation. III. 
Induction of allotype-restricted suppression for IgG antibody responses to individual epitopes on complex 
antigens. Manuscript submitted for publication. 
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obtained following various sequential immunizations with carrier proteins and DNP- 
carrier conjugates shows that  the Igh restriction of epitope-specific regulation dem- 
onstrated for IgG2, allotypes in allotype-suppressed mice  2 extends to the regulation of 
all  isotype  responses.  In  addition,  the  characteristic  pattern  of isotype  responses 
obtained when suppression is weak defines a  hierarchy of suppressibility among the 
isotypes  that  (as  a  practical  matter)  provides  a  reliable  index  for  analyzing  the 
strength  of the  suppression  induced  or  maintained  during  various  immunization 
sequences and consequently for analyzing the stability of epitope-specific regulation. 
Thus, by examining the isotype responses in individual animals immunized with 
different carrier and hapten-carrier sequences, we show that the individual elements 
in the epitope-specific system are typically bistable in that they tend to maintain their 
initially induced regulatory state despite antigenic stimulations that, de novo,  would 
induce them  to the alternate state.  That  is,  when  induced  to support  an  antibody 
response, these elements largely prevent the subsequent induction of suppression for 
that response; and, when induced to suppress a response, they tend to continue to do 
so despite subsequent  immunizations  that  normally induce substantial  support  for 
antibody production. 
In discussing these findings, we point out (a) that most of the properties of epitope- 
specific regulation have been described in idiotype, allotype, or carrier-specific regu- 
latory systems; (b) that the novel bistable properties of the system are recognizable in 
well-known characteristics of primary and anamnestic  (memory) responses;  (c)  that 
these properties are also recognizable in mechanisms that maintain partial or complete 
"nonresponsiveness"  to  individual  epitopes;  and  (d)  that  cell-mediated  immune 
responses are apparently mediated by a similar epitope-specific system. 
Materials and Methods 
The methods used for studies presented here are described in the preceding paper (3). 
Results 
The isotypes represented in anti-DNP antibody responses differ characteristically 
in their sensitivity to the suppression mediated by the epitope-specific system (Table 
I). IgM responses are the most refractory to suppression. These responses are indistin- 
guishable in control (hapten-carrier-primed) and suppressed (carrier/hapten-carrier- 
immunized) mice and remain so after subsequent stimulation with the hapten on the 
same or an unrelated carrier. IgG anti-hapten responses, in contrast, are suppressed 
in  essentially all carrier/hapten-carrier-immunized animals  and,  for some isotypes, 
tend to remain suppressed despite repeated hapten stimulations. 
IgG1  anti-hapten  responses differ qualitatively from responses in  the other three 
IgG isotopes visa vis initial sensitivity to suppression induction and maintenance of 
suppression  once  induced.  Data  from  >2,000  animals  examined  in  the  course  of 
studies exploring the mechanisms that induce and mediate epitope-specific suppres- 
sion  (2)  indicate that  IgG1  responses in individual animals  (a) overlap with control 
responses more frequently after initial suppression induction under optimum condi- 
tions;  (b)  tend to be suppressed  in fewer animals under suboptimum conditions for 
suppression induction; and (c) escape from suppression more frequently than the other 
IgG isotypes after a given number of restimulations with the hapten. 
For example, as  data in  Fig.  1 show,  IgG1  responses escape from suppression  in HERZENBERG,  TOKUHISA,  PARKS,  AND  HERZENBERG 
TABLE  I 
Epitope-speczfic  System Selectively  Regulates lsotype Representation  in 
Antibody  Responses 
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Immunizations:l: 
Relative anti-DNP levels in serum* 
IgM  IgG~  Ig63  IgGib  IgG2. 
--, DNP-KLH  1  1  1  1  1 
KLH DNP-KLH  2  0.5  0.3  0.4  0.2 
--, DNP-KLH DNP-KLH  3  10  8  13  7 
KLH DPN-KLH DNP-KLH  4  8  2  1  0.3 
* Mean  responses (normalized to primary response to DNP-KLH)  measured 
by  RIA  2  wk  after  last  immunization  (3).  See  Fig.  1  or  Table  II  for 
representative  (absolute)  IgGl  and  IgG~  responses in  individual  animals. 
IgGl  responses in  KLH/DNP-KLH/DNP-KLH  animals were broadly dis- 
tributed  (see Fig.  2);  other responses were more tightly grouped around the 
mean response shown. 
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FIG.  l.  The epitope-specific system selectively regulates isotype (subclass) representation in anti- 
body responses. Each point in the figure represents the anti-DNP responses obtained in an individual 
(BALB/c X SJL)FI  animal. Animals were immunized with  100 gg alum-precipitated KLH (K) or 
DNP-KLH (DK) at 6-wk intervals. Anti-DNP responses (serum antibody levels) were measured by 
RIA (3)  2 wk after the last indicated immunization. A, m situ  1  °  DNP-KLH (0) and KLti, DNP- 
KLH (O); B, in situ 2 °  DNP-KLIt, DNP-KLtt  (0) and KLtt, DNP-KLH, DNP-KLtt  (O). 1744  BISTABLE  REGULATION OF ANTIBODY  PRODUCTION 
Initial KLH Dose Determines 
Tntensity  of Suppression 
KLH on Alum 
100  K,DK I] 1¢o.21 
10  K,DK ~1 (<o.~l 
0.1  K,DK ~  (q 
O.001  K,DK I  t  (2) 
-  DK  |  I  (31 
/ 
16o 
100  K,DK,DK I  10  K,DK,DK  11001 
0.1  K,DK,DK  I (2oo) 
0.001  K,DK,DK  ] 1200) 
-  DK,DK  I (300) 
~o  ~o 
Zgh-la 
r 
anti-DNP  (ug/ml) 
[¢O.2  i 
I  [o.~1 
t  (o.8} 
I  (0.7) 
I  (o.8) 
16o  ~6o 
I  (so) 
i (2oo) 
(2oo) 
i  ('~ol 
I  Doo) 
-~o  ~o 
'rgh-4a 
F[o. 2.  Initial KLH dose determines the intensity of the anti-DNP suppression induced  by the 
KLH/DNP-KLH immunization  sequence. Animals (BALB/c) were stimulated first with KLH, as 
indicated, and then twice with DNP-KLH (100/~g on alum) 4 wk and 6 wk later. Responses shown 
were measured 2 wk after each of the last two stimulations. Data in parentheses after each response 
bar shows the average  affinity  (Ka M -] ×  108) for the response (3). Anti-KLH responses (not 
shown) were optimum at the 100/~g KLH dose but were substantial  even at the 10/~g dose (30- 
100% of the primary and subsequent  responses, depending  on  the group  tested).  Responses to 
aqueous  KLH were lower initially but comparable to the KLH plus alum-stimulated  responses 
after two or more stimulations. K, KLH; DK, DNP-KLH. 
about one-half the keyhole limpet hemocyanin  (KLH)3/DNP-KLH-immunized  ani- 
mals  reimmunized  with  DNP-KLH  6  wk  later, whereas  IgG2, anti-DNP  responses 
remain suppressed in essentially all of these animals. IgG2b and IgG3 responses behave 
similarly  to  IgG2,.  That  is,  responses  in  these  latter  three  isotypes  tend  to  escape 
concordantly  when  suppressed  animals  have  been  immunized  three  or  more  times 
with  the  hapten,  even  though  each  of  these  isotypes  escaped  from  suppression 
independently  in  10-20%  of  the  (roughly  200)  animals  in  which  all  IgG  isotype 
responses were examined (data not shown). 
This characteristic isotype hierarchy prevails in animals in which the induction of 
epitope suppression is either genetically impaired (2, 3) or experimentally minimized 
by immunizing initially with low doses of the carrier protein (Fig. 2). In fact, whenever 
suppression  is weak initially or begins to wane after repeated antigenic stimulation, 
IgGt  antibody  responses  are  always  the  first  to  appear  (2).  Thus,  the  distinction 
between IgG] and the other more suppressible IgG isotypes provides a  reliable index 
for evaluating experimental conditions that interfere with suppression induction. 
Epitope-specific  Regulation  Is Igh  Restricted.  We show  here that  the epitope-specific 
system  selectively regulates  the  production  of the  various  isotypes represented  in  a 
given anti-epitope response.  Furthermore,  we show  that  the epitope-specific system 
can be induced to suppress Igh-1 b  (IgGz, allotype) responses to individual epitopes in 
an  allotype  heterozygote  without  interfering  with  production  of  the  (allelically 
:3Abbreviations used in this paper:  1)NP, dinitrophenyl  hapten; TNP, trinitrophenyl  hapten;  PC, phos- 
phoryl-choline hapten; CGG, chicken gamma globulin; KI,H, keyhole limpet hemocyanin; TGAL ((T,G)- 
A-I,), po[y-t.-(tyrosine, glutamic acid)-poly-r)]-alanine-poly-i -lysine; RIA, solid-phase radioimmune  assay. HERZENBERG, TOKUHISA, PARKS, AND HERZENBERG  1745 
determined) Igh-la responses to the same epitopes.  2 These findings demonstrate that 
epitope-specific regulation  is  mediated  by  independent  elements whose  regulatory 
potential is restricted to controlling the production of antibodies with  the same or 
closely related combining-site structures  and  a  single  heavy chain  constant  region 
structure (allotype/isotype). 
This  Igh  constant  region  restriction  appears  to  be  based  on  the  recognition  of 
allotypic rather than isotypic structures. That is, because isotypic structures are shared 
between  allotypically  different  heavy  chains,  isotype-restricted  regulation  cannot 
explain  the  selective  regulation  of Igh-lb  allotype  antibodies.  Allotype-restricted 
regulation,  in  contrast, can clearly account  for selective isotype regulation  because 
nearly all  Igh  allotypic structures are unique  to  (and  thus can  identify) the  heavy 
chain isotype on which they are found. Thus, it is likely that the selective regulation 
of both isotype and allotype representation in individual anti-epitope responses derives 
from a  requirement for recognition of polymorphic (allotypic) regions of Igh heavy 
chain constant regions. 
Initiation  of  Antibody Production Specifically Impairs  Subsequent  Suppression-Induction. 
Studies conducted in the early  1970's  (5) demonstrated that carrier-primed animals 
immunized with  DNP on the priming carrier produce relatively normal secondary 
anti-DNP responses if the animals have previously been immunized with the hapten 
on  an  unrelated  carrier.  These data,  obtained  before the  "suppression  era,"  were 
commonly  interpreted  as  indicating  that  antihapten  memory  B  cells  cannot  be 
induced de  novo by carrier/hapten-carrier  immunization  but,  once present,  can  be 
expressed normally in  response to immunization with the hapten-carrier conjugate 
presented in the sequence. 
We  now  show,  however,  that  anti-hapten  anti-DNP  memory  B  cells  develop 
normally but are not expressed after carrier/hapten-carrier immunization  (3).  Fur- 
thermore, we show directly that  anti-DNP  responses fail in carrier/hapten-carrier- 
immunized animals because this immunization sequence induces the epitope-specific 
system  to  suppress  the  expression  of  these  memory  cells.  Thus,  viewed  from  a 
contemporary perspective, the restoration of responsiveness demonstrated in the early 
1970's and reproduced here (see below) would appear to be the result of mechanisms 
that  interfere  with  the  induction  of epitope-specific  suppression  once  a  primary 
antihapten response has been initiated. 
Data presented in Table II confirm this conclusion by showing that  an ongoing 
primary response attenuates rather than prevents the subsequent  induction of sup- 
pression by the carrier/hapten-carrier sequence. In essence, the anti-hapten responses 
obtained  under  these  conditions  are  typical  of responses  obtained  whenever  the 
suppression-induction stimulus is weakened, i.e., IgG1 tends to be produced normally, 
whereas IgG2a, IgG2b, and IgGs responses tend to be suppressed. 
For  example,  primary  IgG1  anti-DNP  responses  in  DNP-KLH-primed  animals 
generally rise to normal secondary response levels when these animals are immunized 
subsequently  with  the  CGG/DNP-CGG  sequence.  IgG2a  anti-DNP  responses,  in 
contrast, rise to secondary levels in some animals but  become suppressed  in others. 
Sometimes this suppression  is  incomplete;  however, in  many animals,  the ongoing 
primary IgG2a anti-DNP response essentially terminates after completion of the CGG/ 
DNP-CGG immunization sequence and  IgG2a anti-DNP  levels in serum  fall to the 
minimal, low-affinity anti-DNP response levels characteristic of epitope-specific sup- 1746  BISTABLE REGULATION  OF ANTIBODY PRODUCTION 
TABLE  II 
Prior Hapten-Priming Impairs Epitope-specific Suppression Induction 
Immunizations* 
IgG anti-DNP responses in 
individual animals* 
IgG2.  IgG~ 
DNP-CGG,--,DNP-KLH 
DNP-KLII,--,DNP-CGG 
DNP-CGG, KLH, DNP-KLH 
DNP-KLH, CGG, DNP-CGG 
KLH, DNP-CGG, DNP-KLH 
CGG, DNP-KLH, DNP-CGG 
~g/ml (Ka) 
68 (70)  45 (40) 
66 (100)  60 (200) 
168 (50)  150 (50) 
36 (70)  180 (70) 
106 (>400)  150 (300) 
184 (150)  550 (300) 
12 (l)  210 (100) 
16 (4)  360 (300) 
33 (5)  600 (300) 
6 (<0.3)  30 (200) 
37 (40)  70 (40) 
60 (200)  200 (150) 
10 (<0.3)  25 (1) 
17 (0.5)  40 (5) 
124 (100)  190 (20) 
5 (1)  430 (80) 
22 (2)  90 (20) 
24 (0.5)  150 (30) 
* Each line in the table shows the response from an individual animal measured 
by  RIA  (4)  2 wk  after  the  last (third) antigenic stimulation.  Low  level 
(suppressed) responses  are substantial overestimates of the actual amount of 
antibody being produced at time of measurement and should be corrected 
downward by roughly 5 /~g  to  account  for  the  contribution  of primary 
response antibody that has not decayed in the 2 wk between challenge and 
test. (Ka) = Ka M  -1 x  l0  s (4). 
:~ 100  ~g  of  indicated  antigen  on  alum  injected  intraperitoneally  into 
BALB/c mice at 0, 6, and 8 wk; primary responses to DNP were normal in 
all mice. 
pression (Table II). IgG2b and IgGa responses also tend to be completely suppressed in 
these latter animals, although the concordance is not absolute (data not shown). 
Epitope-specific suppression can therefore be induced, and subsequent memory B 
cell expression can be prevented, even after a  primary response has  been initiated. 
Nevertheless,  the  initiation of a  primary  response  clearly  impairs  the  subsequent 
induction of suppression, particularly for certain isotypes. Thus, our findings define 
an overall regulatory system capable of selectively regulating IgG isotype responses to 
individual epitopes and of maintaining (or shifting) the responses produced according 
to the conditions under which the epitope is introduced. 
Similar isotype selectivity was  noted in the original studies (cited above)  demon- 
strating that ongoing primary responses attenuate the effects of carrier/hapten-carrier 
immunization. This  failure  to  restore  certain  isotype  responses  was  (reasonably) 
discounted at the time as perhaps the result of selective "adjuvant effects" on memory 
B cell priming (5); however, reconsidered now, the carefully reported data from these 
studies essentially provides the outlines of the bistable, Igh-restricted epitope-specific 
regulatory system described here. HERZENBERG,  TOKUHISA, PARKS,  AND  HERZENBERG  1747 
Epitope-specific Regulation Is Bistable.  DNP-CGG/KLH/DNP-KLH immunization 
results in the production of substantially better anti-DNP responses than KLH/DNP- 
KLH/DNP-CGG  immunization, even  though  the  responding  animals  have  been 
immunized with  the same  amounts of each  antigen  at  similar  intervals  (compare 
Table II and Fig. 2). Thus, antigenic stimulations that induce strong suppression in 
naive animals are no longer capable of inducing such suppression once an antihapten 
response  has  been  established;  and,  similarly, antigenic  stimulations  that  induce 
antibody  production  in  naive  animals  are  relatively  ineffective in  doing  so  once 
suppression has been established. 
Comparison  of the anti-DNP  responses  produced  after DNP-CGG/KLH/DNP- 
KLH immunization with responses produced in KLH/DNP-KLH-suppressed animals 
when the KLH dose is reduced  10-fold (from 100 #g to 10/zg)  demonstrates that the 
initiation of a primary antihapten response is functionally equivalent to reducing the 
strength of the carrier-specific mechanism that induces the epitope-specific system to 
suppress  antibody production  (Table II and Fig. 2).  In both cases, the suppression 
obtained  is  restricted  to  the  "more suppressible"  isotypes and  is  demonstrable  in 
essentially the same proportion of immunized animals. 
Weakening the effector mechanism that maintains epitope-specific suppression has 
a similar effect. That is, KLH/DNP-KLH-immunized animals stimulated repeatedly 
with either DNP-KLH or DNP-CGG eventually produce normal secondary-level IgG 
antihapten responses. However, while recovering from suppression, these animals pass 
though a stage during which they produce selectively suppressed responses comparable 
to those produced  by animals in which suppression-induction  is  initially impaired 
either by prior hapten-priming or by suboptimum carrier stimulation (e.g., compare 
Tables I and II and Fig. 2). Thus, the order of antigenic stimulations determines the 
responses  produced  at  any  given  point  in  a  stimulation  sequence,  but  the  rules 
governing  which  responses  are  suppressed  are  the  same,  whether  animals  are  in 
transition from suppression to full responsiveness or vice versa. 
The epitope-specific elements that individually control the production of antibodies 
with common Ig heavy chain and antibody combining-site structures, therefore, have 
the  following properties:  (a)  they can be  independently induced to  provide either 
support  or  suppression  for  antibody  production;  (b)  they  tend  to  maintain  their 
initially induced state despite subsequent antigenic stimulation(s) that would induce 
the alternate state in unprimed animals; and (c)  they remain capable of shifting to 
the  alternate  state  when  confronted  with  sufficiently strong  stimulation  favoring 
establishment of that state. Thus, these elements are typically bistable, and, acting as 
a  system, constitute  a  unique  adjunct  to  immunologic memory that  permits  the 
conditions surrounding  the  first  exposure  to  an  epitope  to  strongly  influence the 
composition of initial and subsequent antibody responses to that epitope. 
Discussion 
Surprisingly, although the epitope-speciflc regulatory system introduces a  funda- 
mentally new mechanism central to the control of heterogeneous antibody responses, 
almost every aspect of this mechanism appears to have been studied previously. The 
T  cell control of B cell expression according to Ig combining-site committment, for 
example, has been extensively examined in idiotype-suppression systems (e.g.,  6-9). 
Similarly, selective control  according  to  Ig  heavy chain  constant  region  structure 1748  BISTABLE REGULATION OF ANTIBODY PRODUCTION 
recalls evidence from "chronic" allotype suppression studies in which suppressor T 
cells  specifically prevent production of antibodies carrying one of the two parental 
IgG2a heavy chain allotypes in an allotype heterozygote (10,  11). Thus, the effector 
mechanism mediating epitope-specific suppression  is  novel mainly in  its ability to 
combine the properties of Ig-oriented mechanisms that have previously been studied 
independently. 
Similarly, although we (and many of our colleagues) were initially surprised to find 
that  immunization  with  (what  we  now  call)  the  carrier/hapten-carrier  sequence 
resulted in suppressed rather than augmented antihapten responses, a cursory litera- 
ture search revealed that this phenomenon was well known some time ago. In fact, 
the first (and often cited) papers demonstrating that spleen cells from carrier-primed 
animals  provide  carrier-specific  help  for  antihapten  memory  B  cells  in  adoptive 
cotransfer assays also  noted  clearly that  the  carrier-primed  donors  used  for  these 
experiments produce very little antihapten antibody when stimulated in situ with the 
homologous hapten-carrier conjugate (12,  13). 
During the intervening years, this unexplained response failure came to be attrib- 
uted to interference with antihapten memory B cell development. Our studies refute 
this hypothesis directly by showing that these mice have normal antihapten memory 
B cell populations (1, 3). Furthermore, we show that the expression of these memory 
B  cells is specifically suppressed,  that carrier/hapten-carrier  immunization induces 
this suppression (which is mediated by the epitope-specific system), and, finally, that 
carrier-specific suppressor T  cells  (CTs)  present in carrier-primed mice induce such 
epitope-specific suppression when confronted with the hapten on the priming carrier. 
Carrier  priming,  of course,  has  long  been  known  to  generate  CTs  capable  of 
suppressing adoptive and in vitro antihapten responses to haptens presented on the 
priming carrier  (e.g.,  14-16).  The presence of these cells,  however, did not appear 
relevant  to the specific failure of the in  situ  antihapten response in carrier/hapten- 
carrier-immunized animals, largely because of confusion introduced by assuming that 
the  CTs  specificity  for  the  carrier  protein  meant  that  they  controlled  antibody 
production by depleting carrier-specific help. CTs activity in situ thus seemed mini- 
mum except  in tolerized animals  (e.g.,  17)  and, in any event, could not explain a 
specific inability to produce antibody to the "new" epitope (hapten) on the carrier. 
Our  recent  studies  (conducted with  Dr.  Masuru Taniguchi  in  his laboratory at 
Chiba  University, Chiba, Japan),  however, demonstrate clearly that  CTs suppress 
antibody production by inducing epitope-specific suppression rather than by reducing 
the supply of carrier specific help (3, 18). This conclusion, which is entirely consistent 
with data from previous CTs studies, is based on a  more extensive analysis showing 
that the specificity of the suppression obtained in CTs recipients is identical to the 
suppression  obtained  in carrier/hapten-carrier-immunized  animals. CTs,  therefore, 
emerge in a new regulatory role (as inducers of specific suppression for in situ responses 
to epitopes presented on the carrier protein under certain conditions), which explains 
the previously puzzling presence of these cells (19) in spleens from animals recently 
primed with a carrier protein and producing a normal anti-carrier antibody response. 
The bistable mechanism that permits the epitope-specific system to establish either 
support or suppression for individual antibody responses constitutes perhaps the most 
surprising capability of this system given the data available from currently studied 
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becomes quite familiar when  considered within  the context of common experience 
garnered in the production of antibody "reagents" for use in immunogenetic, phylo- 
genetic, or structural studies. Serologists have long known that antibody responses in 
individual  animals  tend  to become fixed early in  the response with  respect  to the 
epitopes detected and the isotypes produced. Such response characteristics, commonly 
attributed  to  (B  cell)  "clonal  dominance,"  flow naturally  from  the operation of a 
bistable regulatory system that maintains initially defined response states for individ- 
ual determinants on complex antigens. 
That is, the initial presentation of an antigen (i.e., a carrier molecule and its native 
epitopes)  must  generate something of a  horserace between the operation of mecha- 
nisms  that  stabilize  epitope-specific elements to support  antibody production  (and 
prevent suppression induction) and the maturation of carrier-specific CTs that, once 
functional, induce the remaining "unstabilized" epitope-specific elements to suppress 
antibody production.  Furthermore,  the  outcome of this  response-determining race 
must  be largely during the first few days after antigenic stimulation because KLH- 
specific CTs, for example, mature within a week of priming (3,  19). 
Thus,  responses  to epitopes  on  complex antigens  can  be expected to  vary from 
individual  to  individual,  particularly  when  such  epitopes  have  an  inherently low 
probability of inducing antibody production rapidly. Although certain epitopes might 
mimic DNP and universally induce stable antibody production, most will fall prey to 
the suppression-induction mechanism  (independently) in at least some of the immu- 
nized animals. Therefore, individual animals will tend to produce antibodies to more 
or less  random  subsets  of the  epitopes  on  an  immunizing  antigen,  and  the  initial 
specificity pattern  of the  response  will  tend  to  be  maintained  when  animals  are 
repeatedly re-immunized. In other words, the consequences expected from the oper- 
ation of a bistable regulatory system such as we have described predict the response 
patterns commonly observed in serologic studies. 
Studies  on  epitope-specific regulation  in  allotype-suppressed  mice,  2 however, di- 
rectly demonstrate  the  importance of this  bistable  mechanism  in  determining the 
course of subsequent responses to the epitopes on a priming antigen. We have shown 
that  young  Igh-lb  (lb)  allotype-suppressed  mice  primed  with  DNP-KLH  cannot 
produce lb responses to epitopes on the priming antigen. Thus, when these mice enter 
a  remission period during which they can produce normal  lb antibody responses to 
newly introduced epitopes, they remain specifically unable to produce lb anti-DNP 
and  lb anti-KLH antibodies.  Furthermore, they fail to produce lb responses to the 
DNP  hapten  presented during remission on chicken gamma  globulin  (CGG), even 
though they produce normal  lb antibody responses to the CGG determinants on the 
stimulating (DNP-CGG) antigen. 2 
Other  isotype  and  allotype  responses  to  DNP-KLH  epitopes  in  the  allotype- 
suppressed  mice  are  initiated  normally  after DNP-KLH  stimulation  and  proceed 
normally  thereafter.  Thus,  the  inability  to  produce  lb  antibody  responses  to  the 
epitopes  presented  on  DNP-KLH  during  the  period  when  allotype suppression  is 
active results in the induction of a stable and specific suppression for subsequent  lb 
antibody responses  to  these  epitopes,  and  this  epitope-specific suppression  persists 
when  the  allotype suppression  mechanism  ceases  its  activity.  In  other  words,  the 
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defined by conditions in the regulatory environment when the animal first encounters 
a given epitope. 
These findings independently demonstrate the bistable regulatory potential of the 
epitope-specific  system  shown  (in  this  publication)  by  the  contrast  between  the 
minimum suppression obtained for anti-DNP responses in DNP-CGG/KLH/DNP- 
KLH-stimulated animals  and  the  strong  suppression  obtained  after  KLH/DNP- 
KLH/DNP-CGG stimulation. In addition, they independently demonstrate the Igh- 
restricted regulation provided by the individual elements that comprise this system, 
demonstrable in carrier/hapten-carrier-immunized animals mainly by their ability to 
selectively regulate isotype rather than allotype. 
Taken as  a  whole, therefore, the evidence we have presented  indicates that  the 
epitope-specific system plays a central role in defining the magnitude, specificity, and 
isotype/allotype composition of primary and anamnestic  (memory) responses. This 
system is clearly subordinate to mechanisms that influence memory B cell develop- 
ment;  however,  its  ability  to  maintain  itself in  its  initially induced  state  and  to 
selectively  control  the  expression  of memory  B  cells  makes  it  a  key  element  in 
determining how an animal responds to previously encountered epitopes. 
In essence, it provides an effector mechanism through which initial immunization 
conditions can establish the production of functionally relevant isotype responses and 
prevent production of functionally deleterious responses without sacrificing the poten- 
tial for producing a different type of response at a later date. Furthermore, it offers a 
versatile alternative or adjunct to deletional-type tolerance mechanisms in that it can 
maintain partial or complete tolerance to epitopes that have succeeded in generating 
substantial memory B cell activity. 
Analogous mechanisms apparently regulate cellular immune responses. For exam- 
ple, recent studies (20) demonstrate that the induction of allergic encephalomyelitis 
(AE)  by an encephalitogenic peptide-carrier conjugate can be inhibited (suppressed) 
by prior  immunization with  the carrier  protein,  i.e.,  by carrier/hapten-carrier  im- 
munization. Similarly, the mechanisms regulating delayed-type hypersensitivity (21) 
show  a  specificity  for  epitopes  not  unlike  the  mechanisms  described  here.  Thus, 
although the epitope-specific system as such has only recently been recognized, the 
consequences of epitope-specific regulation have apparently been known in various 
guises for many years. 
The cell interactions responsible for this intricately balanced regulatory system, in 
contrast, are  not readily extractable  (at  least as a  unit)  from any of the currently 
known  mechanisms  controlling  antibody  production  or  cellular  immunity.  Such 
interactions,  however,  constitute  the  heart  of the  regulatory  "circuit"  model  we 
proposed  some time ago  (22,  23).  The bistable  "core" circuit  in  this model  is  Igh 
restricted and epitope specific; it regulates the expression of memory B cells, and it is 
induced to suppress or support antibody production by various "environment-sensing" 
(carrier-specific, allotype-specific) auxiliary circuits. This theoretical exercise, there- 
fore, suggests a plausible (although not necessarily correct) cellular basis for epitope- 
specific regulation. 
The induction of epitope-specific suppression by either carrier-specific or allotype- 
specific mechanisms is predictable  (with hindsight)  from the principles that guided 
construction of this model. Similarly, recent studies  (24) demonstrating contrasup- 
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carrier-specific suppressor T  cell and its contra-suppressor T  cell counterpart, would 
be expected to vie with one another (and with other types of regulatory cells)  for the 
dominating position visa vis the stabilization of epitope-specific elements to support 
or suppress responses. 
In  essence  then,  the evidence we present  casts  the epitope-specific system as an 
integrative central mechanism responsible for shaping humoral and cellular responses 
according  to  the  dictates  of the  regulatory environment  when  an  antigen  is  first 
introduced. The complexity inherent in such a system is staggering; but the confusion 
it generates for us (as observers)  is clearly balanced by the stunning simplicity of a 
mechanism evolved to funnel broadly diverse regulatory influences through a  single 
set  of gates  that  ultimately say "yea" or  "nay" to  the  production  of the  various 
antibodies and cellular responses possible after antigenic stimulation. 
Summary 
Antibody responses to commonly used antigens are regulated by an epitope-specific 
system composed of Igh-restricted elements responsible for controlling the isotype and 
allotype responses  mounted to each of the epitopes on  the antigen.  Because these 
elements  can  be  independently  induced  to  either  suppress  or  support  antibody 
production,  this  system  as  a  whole  provides  an  effector  mechanism  capable  of 
selectively controlling the amount, affinity, isotype representation, and epitope-spec- 
ificity of an antibody response. 
Sequential immunizations with a carrier molecule and a hapten conjugated to that 
carrier (carrier/hapten-carrier immunization) induce suppression for IgG responses to 
the  hapten.  IgG2a,  IgG2b, and  IgG3  responses  are  easily suppressed,  whereas  IgGx 
responses tend to be more resistant. Once induced, suppression tends to be maintained; 
however, repeated stimulation with the hapten  (on any carrier)  eventually induces 
antibody production, first for IgG1 and later for the more suppressible isotypes (IgG2a, 
IgG~b, IgGz). 
Antibody production, once initiated, also tends to be  maintained. Ongoing IgG 
antihapten  responses  in  animals  primed  with  a  hapten-carrier  conjugate  can  be 
suppressed  by  subsequent  carrier/hapten-carrier  immunization  (using  a  different 
carrier  molecule);  however,  the  suppression  induced  under  these  circumstances  is 
substantially weaker, i.e., it mainly affects the more suppressible isotypes and is only 
strong enough to detect clearly in about one-half the immunized animals. Thus, the 
initiation of antibody production  impairs the subsequent  induction of suppression, 
and  the  initial  induction of suppression  tends  to  prevent  subsequent  initiation of 
antibody production. 
This reciprocal relationship defines a bistable regulatory mechanism, i.e., one that 
tends to maintain its initially induced state but is capable of shifting to the alternate 
state when stimulatory conditions so  dictate. The  operation of such  a  mechanism 
permits conditions surrounding the first immunization with an epitope (hapten)  to 
strongly influence but  not absolutely determine which and how many of the anti- 
epitope memory B  cells generated by that  immunization will subsequently be  ex- 
pressed. Thus, epitope-specific regulation, although subordinate to mechanisms that 
control memory B cell development  (as opposed to expression), plays a  key role in 
determining the magnitude, affinity, and isotype representation ofanamnestic (mem- 
ory) responses produced in response to previously encountered epitopes. 1752  BISTABLE REGULATION OF ANTIBODY PRODUCTION 
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